Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Choosing between index funds and ETFs depends on trading needs, costs, and tax considerations. This guide outlines practical decision factors for you.
14,608 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Massive performance-based bonuses paid to semiconductor workers are drawing scrutiny from the Bank of Korea as the ce...
A legendary macro investor who warned about the 2008 bubble has sold Alphabet and moved into AI hardware names, signa...
Ripple has won preliminary approval for a MiCA-based CASP license in Luxembourg, paving the way for regulated crypto ...
France endures an early-summer heat wave with temperatures above 104°F, red alerts across half the country, and risin...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
A zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
Lennar's latest results reveal a pricing move not seen in years. This article breaks down why lennar hasn't sold home...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
When people search for help, they expect safety—not identity theft. A real-world case shows how simple online searche...
Strategy’s market value has slipped below the value of its own Bitcoin holdings, reversing years of a premium for BTC...
Binance warns it may fail to win MiCA authorization by July 1, risking a European access cut. Traders face a scramble...